Biocytogen
Biocytogen specializes in developing gene-targeted animal models for life science research, offering customized mouse models, phenotype analysis, and extreme genome editing platforms. It also provides integrated solutions for antibody drug development, including animal model generation, therapeutic antibody discovery, and preclinical validation studies.
Top Sectors
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
1 past transactions
Doma Biopharmaceutical
Series A in 2022
Doma Biopharmaceutical is a biotechnology company focused on independent drug research and development. It specializes in the creation of fully human monoclonal and bispecific antibodies, leveraging proprietary platforms that integrate in vivo drug efficacy screening with robust clinical development expertise. This streamlined approach enhances the overall drug development process, enabling global partners to efficiently produce a diverse range of antibody-based therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.